Because the Mongolian gerbil (Meriones unguiculatus) survives more than twice as long as the mouse after doses of ionizing radiation sufficient to cause GI death, a correlation between survival time and the rate of development of the fatal lesion has been postulated. Autoradiographic methods were used to follow labeled epithelial cells as they migrated from the base of the crypts to the tips of the villi in the terminal ileum and to compare renewal rates for both normal and sublethally irradiated gerbils and mice. This renewal time was found to be in excess of 120 hours for the normal Mongolian gerbil in contrast to about 48 hours for the Swiss mouse. In addition, the migration rate was effectively attenuated by sublethal irradiation in both species. This effect was most striking in the case of the gerbil where extrapolation of renewal time data indicates an increase in renewal time of at least 20% over unirradiated controls; this was more than twice the increase demonstrated by the mouse. The observed difference in survival times is consistent with this difference in epthelial renewal rates, and may be a major factor contributing to the long survival time of supralethally irradiated gerbils, particularly when radiation attenuation of migration is considered.
Skip Nav Destination
Close
Article navigation
1 February 1972
Research Article|
February 01 1972
Influence of Intestinal Mucosal Renewal Rate on Development of Gastrointestinal Injury and Survival Time of Irradiated Gerbils
Radiat Res (1972) 49 (2): 367–380.
Citation
John M. Nelson; Influence of Intestinal Mucosal Renewal Rate on Development of Gastrointestinal Injury and Survival Time of Irradiated Gerbils. Radiat Res 1 February 1972; 49 (2): 367–380. doi: https://doi.org/10.2307/3573274
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner